The cost-effectiveness of the Argus II retinal prosthesis in Retinitis Pigmentosa patients. - sprookjes - yvandenbroek - TriplyDB

The cost-effectiveness of the Argus II retinal prosthesis in Retinitis Pigmentosa patients.

The cost-effectiveness of the Argus II retinal prosthesis in Retinitis Pigmentosa patients.

http://www.wikidata.org/entity/Q35147398

about

Utilizing Zebrafish Visual Behaviors in Drug Screening for Retinal Degeneration Worldwide Argus II implantation: recommendations to optimize patient outcomes.Retinal Prosthesis System for Advanced Retinitis Pigmentosa: A Health Technology Assessment.Electronic retinal implants and artificial vision: journey and present.Emerging therapies for inherited retinal degeneration.Quantitative analyses of factors related to anxiety and depression in patients with retinitis pigmentosa.The Argus-II Retinal Prosthesis Implantation; From the Global to Local Successful Experience

P2860

Q33838630-1A8EA842-2FBB-4CB4-907C-4248DFF1589D Q36875796-4D44FC8C-68DF-4CC2-A27B-B866BD95820D Q37101490-EF71B932-DE5A-4281-8C90-AFCF7428D1FD Q38557561-FCF7DDC9-9768-4407-B588-A857C2934F30 Q39032340-AFA646DE-3297-4905-85DF-6148D9DD86A4 Q55113998-E9003EBA-7EE7-43C8-AF89-8BB897787C55 Q58762782-E1DBCFE2-54A9-4FC6-8E45-16253C0E4277

P2860

The cost-effectiveness of the Argus II retinal prosthesis in Retinitis Pigmentosa patients.

http://www.wikidata.org/entity/Q35147398

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The cost-effectiveness of the ...... Retinitis Pigmentosa patients.

@ast

The cost-effectiveness of the ...... Retinitis Pigmentosa patients.

@en

type

label

The cost-effectiveness of the ...... Retinitis Pigmentosa patients.

@ast

The cost-effectiveness of the ...... Retinitis Pigmentosa patients.

@en

prefLabel

The cost-effectiveness of the ...... Retinitis Pigmentosa patients.

@ast

The cost-effectiveness of the ...... Retinitis Pigmentosa patients.

@en

P1433

Q35147398-E3A826CB-965F-4BFF-9039-20CD7E4A9308

P1476

Q35147398-BD54DDD1-D58A-4850-A7F9-859708E905CE

P2093

Q35147398-0804E74D-AAE5-4EEC-93A0-5F839E4180DB

Q35147398-20CC6599-80D4-400F-8016-66BB3923EA00

Q35147398-BB5A5B1C-5937-4A65-9184-BC47998B76D0

Q35147398-DAFC4817-1EEC-4896-B994-F26687A2FA78

P2860

Q35147398-26D3E4A6-FB68-4012-A370-A33D0DED7110

Q35147398-2CE48E6F-3F58-46CA-AF4E-86C0FDA5E13C

Q35147398-37A0B483-F242-417C-9E88-4382A2D470D5

Q35147398-38C3A772-B0B6-42B7-A2EE-3DEE63C6ABEA

Q35147398-3B4A17BA-B224-4F32-B649-BCBDA714BCB5

Q35147398-455FF254-FC7E-40E0-9A52-348D8616EEC5

Q35147398-47670721-753B-4104-A1B1-90C895A81DB2

Q35147398-52892B91-EB57-4310-9B44-1C5BE6DA2BB7

Q35147398-5919D801-A863-4253-98D0-D15A2315FB20

Q35147398-8063BDDA-23FA-4114-8125-252D807DCCF6

P2888

Q35147398-FBCF1AFC-5B1A-42C8-8D88-8C9A76EB58C1

P304

Q35147398-416F181D-4A16-40C8-AC64-4674605D2A17

P31

Q35147398-36CD1FA0-FA18-4016-A1F4-F713E7EB0F65

P356

Q35147398-F379C5CE-A51E-4B16-94C7-38EA732B3061

P478

Q35147398-247C8ADF-7D9C-45F8-A2C6-CB0688D95F17

P50

Q35147398-150C09EE-D028-4202-8972-99CB4D26659D

Q35147398-4B12EB83-2BB8-4244-AED4-66880E2B6B51

Q35147398-69E65F0E-B028-4A08-AA8A-20DDF3FF97CE

Q35147398-7688B3A8-54C4-4287-8BAD-C1E5E6A0318A

P577

Q35147398-CEEE9EE0-1066-4CD6-A57B-4FD6AF5F1B87

P5875

Q35147398-AF66A9C2-68A4-40CC-A7CA-7B8D9645BDA8

P6179

Q35147398-C694A346-DAF5-43ED-ABD3-0ED78A4F7212

P698

Q35147398-8A244576-CA19-47E0-8B7F-099B89083F2C

P932

Q35147398-0F26D35C-27C8-4024-861D-879810B52478

P356

1471-2415-14-49

P1433

BMC Ophthalmology

P1476

The cost-effectiveness of the ...... Retinitis Pigmentosa patients

@en

P2093

Amit Kukreja

http://www.w3.org/2001/XMLSchema#string

Anil Vaidya

http://www.w3.org/2001/XMLSchema#string

Elio Borgonovi

http://www.w3.org/2001/XMLSchema#string

Paulo Eduardo Stanga

http://www.w3.org/2001/XMLSchema#string

P2860

Retinitis pigmentosa

National Institute for Clinical Excellence and its value judgments

Interim results from the international trial of Second Sight's visual prosthesis.

Untapped potential of health impact assessment.

Retinitis pigmentosa

Subretinal electrode implantation in the P23H rat for chronic stimulations.

Cone dysfunctions in retinitis pigmentosa with retinal nerve fiber layer thickening.

Review of NICE's recommendations, 1999-2005.

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.

Health care economic analyses and value-based medicine.

P2888

1471-2415-14-49

P304

49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2415-14-49

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

José-Alain Sahel

Stanislao Rizzo

P577

2014-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261733069

http://www.w3.org/2001/XMLSchema#string

P6179

1049278548

http://www.w3.org/2001/XMLSchema#string

P698

24731533

http://www.w3.org/2001/XMLSchema#string

P932

3990272

http://www.w3.org/2001/XMLSchema#string